Emory University's Woodruff Health Sciences: Pfizer Says COVID-19 Vaccine Safe, Spurs Immune Response in Kids Ages 5 to 11
September 22, 2021
September 22, 2021
ATLANTA, Georgia, Sept. 22 (TNSOps) -- Emory University's Woodruff Health Sciences Center issued the following news release:
Initial results from the Pfizer-BioNTech pediatric vaccine trial indicate that the COVID-19 vaccine is safe and triggers an immune response in children ages 5 to 11, the companies announced Sept. 20. The news arrives as the pandemic's toll on children continues to rise; over 13% of all COVID-19 cases in the U.S. and almost 30% of all newly diagnosed . . .
Initial results from the Pfizer-BioNTech pediatric vaccine trial indicate that the COVID-19 vaccine is safe and triggers an immune response in children ages 5 to 11, the companies announced Sept. 20. The news arrives as the pandemic's toll on children continues to rise; over 13% of all COVID-19 cases in the U.S. and almost 30% of all newly diagnosed . . .